Over the past 25 years, the UN Convention on Biological Diversity (CBD) has established a system of global oversight for living (a.k.a. genetically) modified organisms (LMOs) based on the principles of precaution, fairness (equitable sharing of benefits) and prior informed consent. COP 14 and COP-MOP 9 will be key to upholding those principles and ensuring they are extended to the governance of next-generation genetic engineering technologies: i.e., synthetic biology, which increasingly encompasses genome editing and gene drive technologies. […]